These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 1397240

  • 1. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P, Wood L.
    Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
    [Abstract] [Full Text] [Related]

  • 2. Treatment of adult acute lymphoblastic leukaemia.
    Jacobs P, Wood L, Novitzky N.
    Haematol Blood Transfus; 1990 Aug; 33():428-31. PubMed ID: 2323650
    [Abstract] [Full Text] [Related]

  • 3. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR.
    Blood; 1995 Apr 15; 85(8):2025-37. PubMed ID: 7718875
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Colović M, Bogdanović A, Janković G, Kraguljac N, Suvajdzić N.
    Chemotherapy; 2003 Jun 15; 49(3):138-45. PubMed ID: 12815207
    [Abstract] [Full Text] [Related]

  • 5. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH, Camitta BM, Leventhal BG, Shuster JJ, Civin CJ, Ganick DJ, Lauer SJ, Steuber CP, Kamen BA.
    Cancer; 1995 May 15; 75(10):2623-31. PubMed ID: 7736409
    [Abstract] [Full Text] [Related]

  • 6. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb 15; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 7. Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
    Chen YC, Ho CL, Kao WY, Hwang JM, Sheu LF, Chao TY.
    Ann Hematol; 2001 Nov 15; 80(11):647-52. PubMed ID: 11757723
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
    Kobayashi T, Tobinai K, Shimoyama M, Mikuni C, Konda S, Kozuru M, Araki K, Sai T, Fukuhara S, Matsumoto M, Aoki I, Deura K, Oyama A, Hotta T, Abe T, Toki H, Nagai M, Fukuda H, Niimi M, Yamaguchi N, Tajima K, Shirakawa S.
    Jpn J Clin Oncol; 1999 Jul 15; 29(7):340-8. PubMed ID: 10470659
    [Abstract] [Full Text] [Related]

  • 9. Aggressive treatment improves survival in adult acute lymphoblastic leukemia.
    Smedmyr B, Killander A, Simonsson B, Sundström C.
    Eur J Haematol; 1988 Nov 15; 41(5):478-81. PubMed ID: 3208869
    [Abstract] [Full Text] [Related]

  • 10. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct 15; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM, Grañena A, Rozman C, Urbano-Ispizua A, Bladé J, Carreras E, Cervantes F, Marín P, Sierra J, Nomdedeu B.
    Sangre (Barc); 1990 Feb 15; 35(1):26-32. PubMed ID: 2333581
    [Abstract] [Full Text] [Related]

  • 13. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK, Chan LC, Liang R, Lie A, Kwong YL, Todd D, Chan TK.
    Leukemia; 1994 Sep 15; 8(9):1469-73. PubMed ID: 8090027
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    van Eys J, Berry D, Crist W, Doering E, Fernbach D, Pullen J, Shuster J, Wharam M.
    Cancer; 1989 Jan 01; 63(1):23-9. PubMed ID: 2910421
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C.
    Med Pediatr Oncol; 1996 Jan 01; 26(1):10-9. PubMed ID: 7494507
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM, Bunin NJ, Belasco JB, Meek R, Scher C, Lange BJ.
    Med Pediatr Oncol; 2000 May 01; 34(5):313-8. PubMed ID: 10797352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.